Scarica l'app Stockscreener
24.31
0.54%
0.13
Pre-mercato:
24.25
-0.06
-0.25%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché DOCS Giù?
Forum
Previsione
Precedente Chiudi:
$24.18
Aprire:
$24.07
Volume 24 ore:
1.65M
Relative Volume:
0.49
Capitalizzazione di mercato:
$4.49B
Reddito:
$637.78M
Utile/perdita netta:
$239.40M
Rapporto P/E:
20.41
EPS:
1.1909
Flusso di cassa netto:
$307.21M
1 W Prestazione:
-1.98%
1M Prestazione:
-3.15%
6M Prestazione:
-67.33%
1 anno Prestazione:
-60.46%
Intervallo 1D:
$23.93
$24.92
Intervallo di 1 settimana:
$23.53
$25.41
Portata 52W:
$23.53
$76.51
Doximity Inc Stock (DOCS) Company Profile
Nome
Doximity Inc
Settore
Industria
Telefono
(650) 549-4330
Indirizzo
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, WAY
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.31 | 4.49B | 637.78M | 239.40M | 307.21M | 1.1909 |
VEEV
Veeva Systems Inc
|
178.28 | 29.12B | 3.20B | 908.91M | 1.39B | 5.4168 |
BTSG
Brightspring Health Services Inc
|
42.83 | 8.23B | 12.91B | 104.80M | 394.69M | 0.8769 |
TEM
Tempus Ai Inc
|
45.53 | 8.14B | 1.27B | -245.03M | -245.36M | -1.4071 |
HQY
Healthequity Inc
|
83.85 | 7.08B | 1.31B | 215.20M | 408.32M | 2.4627 |
WAY
Waystar Holding Corp
|
24.85 | 4.76B | 1.10B | 112.09M | 283.19M | 0.6096 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Iniziato | RBC Capital Mkts | Outperform |
| 2026-01-08 | Aggiornamento | Truist | Hold → Buy |
| 2025-12-15 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Iniziato | Barclays | Overweight |
| 2025-11-21 | Aggiornamento | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Iniziato | BMO Capital Markets | Market Perform |
| 2025-10-27 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2025-10-10 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Downgrade | Goldman | Neutral → Sell |
| 2025-07-09 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2025-02-07 | Aggiornamento | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Aggiornamento | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Iniziato | Stephens | Equal-Weight |
| 2024-12-04 | Iniziato | Mizuho | Neutral |
| 2024-11-15 | Iniziato | Goldman | Neutral |
| 2024-11-14 | Aggiornamento | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Downgrade | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Aggiornamento | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Aggiornamento | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Aggiornamento | Needham | Hold → Buy |
| 2024-07-18 | Downgrade | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Iniziato | Leerink Partners | Market Perform |
| 2024-01-03 | Iniziato | Barclays | Equal Weight |
| 2024-01-02 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Downgrade | Guggenheim | Buy → Neutral |
| 2023-08-09 | Downgrade | Needham | Buy → Hold |
| 2023-08-03 | Downgrade | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Iniziato | Wells Fargo | Overweight |
| 2022-10-24 | Iniziato | Evercore ISI | In-line |
| 2022-10-13 | Iniziato | BTIG Research | Neutral |
| 2022-09-16 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Iniziato | Truist | Hold |
| 2022-08-05 | Downgrade | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Iniziato | Berenberg | Buy |
| 2022-05-18 | Reiterato | BofA Securities | Neutral |
| 2022-05-18 | Reiterato | Goldman | Buy |
| 2022-05-18 | Reiterato | Guggenheim | Buy |
| 2022-05-18 | Reiterato | Jefferies | Buy |
| 2022-05-18 | Reiterato | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Reiterato | Needham | Buy |
| 2022-04-07 | Iniziato | Guggenheim | Buy |
| 2022-04-04 | Iniziato | BofA Securities | Neutral |
| 2022-02-11 | Iniziato | Goldman | Buy |
| 2021-12-14 | Downgrade | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Iniziato | Jefferies | Buy |
| 2021-11-17 | Iniziato | Robert W. Baird | Outperform |
| 2021-11-10 | Reiterato | Canaccord Genuity | Buy |
| 2021-11-10 | Reiterato | Goldman | Neutral |
| 2021-11-10 | Reiterato | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Reiterato | Needham | Buy |
| 2021-11-10 | Reiterato | Piper Sandler | Overweight |
| 2021-08-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Iniziato | Canaccord Genuity | Buy |
| 2021-07-19 | Iniziato | Goldman | Neutral |
| 2021-07-19 | Iniziato | JP Morgan | Overweight |
| 2021-07-19 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Iniziato | Piper Sandler | Overweight |
| 2021-07-19 | Iniziato | Raymond James | Outperform |
| 2021-07-19 | Iniziato | SVB Leerink | Outperform |
| 2021-07-19 | Iniziato | William Blair | Outperform |
Mostra tutto
Doximity Inc Borsa (DOCS) Ultime notizie
Vanguard reorganizes reporting; affiliates to report DOCS holdings (DOCS) - Stock Titan
Doximity, Inc. (NYSE:DOCS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Fidelity Trend Fund's Doximity Inc(DOCS) Holding History - GuruFocus
Doximity (NYSE:DOCS) Hits New 1-Year LowTime to Sell? - MarketBeat
HIMS or DOCS: Which Digital Health Company Has Greater Growth Potential Today? - Bitget
HIMS vs. DOCS: Which Digital Health Stock Offers Better Upside Now? - TradingView
Doximity stock hits 52-week low at 23.53 USD - Investing.com
E. Ohman J or Asset Management AB Invests $24.70 Million in Doximity, Inc. $DOCS - MarketBeat
Hims & Hers Expands Integrated Digital Healthcare Ecosystem - TradingView
Freedom Capital initiates Doximity (DOCS) with buy rating, $31 price target - MSN
Freedom Capital Initiates Doximity (DOCS) With Buy Rating, $31 Price Target - Insider Monkey
Doximity Inc. (NYSE:DOCS) Presents a Compelling Case for Growth at a Reasonable Price (GARP) Investors - ChartMill
Doximity (NYSE:DOCS) Upgraded to "Strong-Buy" at Freedom Capital - MarketBeat
The Bull Case For Doximity (DOCS) Could Change Following Surge In Physician AI Interest And Concerns - Sahm
Doximity (DOCS) Receives "Buy" Rating from Freedom Capital Marke - GuruFocus
Analysts Offer Insights on Healthcare Companies: Canopy Growth (CGC) and Doximity (DOCS) - The Globe and Mail
Raymond James sees ‘knee-jerk’ AI reaction, reaffirms strong buy on Doximity, Inc. (DOCS) - MSN
Physicians still concerned about AI accuracy amid rapid adoption: survey - Healthcare Dive
Doximity stock is collapsing after hours: Here's why - MSN
A Look At Doximity’s Valuation After New Report On Rapid Physician AI Adoption - simplywall.st
Freedom Capital Markets initiates Doximity stock with buy rating By Investing.com - Investing.com Australia
Freedom Capital Markets initiates Doximity stock with buy rating - Investing.com
SEC files settled insider trading charges against former Chief Revenue Officer of Doximity - FX News Group
Doximity Study Finds Physicians Rapidly Adopting AI, But Accuracy Concerns Persist - The AI Journal
Aquatic Capital Management Buys Doximity Shares - National Today
SEC Sues Ex-Doximity Exec Who Pleaded Guilty to Insider Trading - Bloomberg Law News
Iron Triangle Partners LP Sells 261,300 Shares of Doximity, Inc. - National Today
Iron Triangle Partners LP Sells 261,300 Shares of Doximity, Inc. $DOCS - MarketBeat
Integral Health Asset Management Buys Stake in Doximity - National Today
Assessing Doximity (DOCS) Valuation After A Steep Share Price Pullback - Yahoo Finance
Is Doximity (DOCS) Now Offering Value After A 61% One Year Share Price Slide - simplywall.st
Franklin Resources Boosts Stake in Doximity - National Today
Capital Fund Management S.A. Acquires 108,937 Shares of Doximity, Inc. $DOCS - MarketBeat
Franklin Resources Inc. Increases Stake in Doximity, Inc. $DOCS - MarketBeat
First Trust Advisors LP Lowers Stock Holdings in Doximity, Inc. $DOCS - MarketBeat
Doximity Insider Sells $58,833 in Stock - National Today
Doximity (NASDAQ:DOCS) Insider Sells $63,622.16 in Stock - MarketBeat
Insider Selling: Doximity (NASDAQ:DOCS) Insider Sells $58,833.03 in Stock - MarketBeat
Sitaram Siddharth sells Doximity shares worth $58,833 - Investing.com UK
Sitaram Siddharth sells Doximity shares worth $58,833 By Investing.com - Investing.com Nigeria
Doximity interim PFO Sitaram sells $63,622 in shares - Investing.com
Doximity interim PFO Sitaram sells $63,622 in shares By Investing.com - Investing.com Australia
Doximity (DOCS) interim PFO exercises 5,000 options, sell-to-cover 2,319 shares - Stock Titan
Doximity (DOCS) interim PFO exercises options, converts B to A, sells stock - Stock Titan
Capital World Investors Boosts Stake in Doximity - National Today
Capital World Investors Increases Position in Doximity, Inc. $DOCS - MarketBeat
Doximity upgraded at Raymond James on improving long-term growth visibility - MSN
American Century Companies Boosts Doximity Stake by 60% - National Today
American Century Companies Inc. Has $16.30 Million Position in Doximity, Inc. $DOCS - MarketBeat
What Analysts Are Saying About Doximity Stock - Sahm
Morgan Stanley Smith Barney files Rule 144 notice for DOCS (NYSE: DOCS) - Stock Titan
Doximity Inc Azioni (DOCS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
4.62%
2.94%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):